Clinical outcomes and treatment patterns among Medicare patients with nonvalvular atrial fibrillation (NVAF) and chronic kidney disease.
Lauren E WilsonXuemei LuoXiaoyan LiJack MardekianAlessandra B Garcia ReevesAsheley SkinnerPublished in: PloS one (2019)
Elderly NVAF patients with advanced CKD (Stage 4 or higher) had higher mortality risks and serious clinical outcomes than those with less advanced CKD (Stage 1-3). OAC use was low across all CKD stages, but was associated with a lower mortality risk than no OAC use in the first year post-NVAF diagnosis.
Keyphrases
- chronic kidney disease
- atrial fibrillation
- end stage renal disease
- oral anticoagulants
- left atrial appendage
- direct oral anticoagulants
- left atrial
- heart failure
- catheter ablation
- human health
- middle aged
- type diabetes
- percutaneous coronary intervention
- cardiovascular disease
- healthcare
- acute coronary syndrome
- replacement therapy